38 Stocks Moving In Wednesday's Mid-Day Session

Gainers

• Caladrius Biosciences Inc CLBS climbed 44.6 percent to $9.5601. Caladrius Biosciences shares climbed over 67 percent Tuesday after announcing the company’s CD34+ cell therapy program received FDA regenerative medicine advanced therapy designation for treating refractory angina.
• ADOMANI, Inc. ADOM rose 25.2 percent to $1.41 following last night's PR that the company will enter U.S. electric truck market.
• CLPS Incorporation CLPS rose 22.4 percent to $13.17 after the company released a letter to shareholders. The China-based company said it's working on "enhancing its original financial technology service offerings to expand to international markets, serve international customers, and provide innovative solutions and products to support more world-class technology customers."
• Naked Brand Group Inc NAKD shares gained 18.5 percent to $7.37. Naked Brand and Bendon Limited reported that they have completed their earlier announced merger.
• Neptune Technologies & Bioressources Inc. NEPT climbed 16.4 percent to $3.76 after surging 31.84 percent on Tuesday.
• Intelsat S.A. I shares climbed 15.4 percent to $18.53 after falling 2.78 percent on Tuesday. RBC Capital upgraded Intelsat from Sector Perform to Outperform.
• Eidos Therapeutics, Inc. EIDX gained 14.7 percent to $19.50. Eidos Therapeutics priced its IPO at $17 per share.
• New Age Beverages Corporation NBEV rose 13 percent to $2.35.
• Sangamo Therapeutics, Inc. SGMO rose 12.9 percent to $18.575. Bank of America initiated coverage on Sangamo Therapeutics with a Buy rating and a $24 price target.
• Synaptics Incorporated . SYNA surged 11.6 percent to $54.495 in reaction to M&A news. The company designs technologies to bring innovative and intuitive user experiences to intelligent devices and confirmed Tuesday afternoon it is in talks to sell itself to Dialog Semiconductor.
• Apollo Endosurgery, Inc. APEN rose 11.6 percent to $6.25. Apollo Endosurgery priced its 3.747 million share offering at $5.50 per share.
• Moleculin Biotech, Inc. MBRX rose 11.6 percent to $2.2431. The clinical stage pharmaceutical company that develops oncology drug candidates said it received approval from the Polish National Office to begin a phase 1/2 clinical trial of its Annamycin for the treatment of relapsed or refractory acute myeloid leukemia.
• TPI Composites, Inc. TPIC climbed 11.5 percent to $28.77.
• Winnebago Industries, Inc. WGO shares gained 11.3 percent to $44.90 after the company reported stronger-than-expected results for its third quarter.
• Audentes Therapeutics, Inc. BOLD rose 11.2 percent to $45.42.
• RumbleON, Inc. RMBL rose 11 percent to $6.65.
• Tesaro, Inc. TSRO shares gained 10.5 percent to $44.19.
• Navigator Holdings Ltd. NVGS shares rose 9.9 percent to $12.25.
• STAAR Surgical Company STAA climbed 9.7 percent to $32.250 after the company reported the resolution of FDA Warning Letter.
• Nortech Systems Incorporated NSYS rose 8.4 percent to $3.50.
• P. H. Glatfelter Company GLT climbed 7 percent to $19.66. DA Davidson upgraded P. H. Glatfelter from Neutral to Buy.
• HUYA Inc. HUYA gained 6.3 percent to $45.415 after dropping 12.04 percent on Tuesday.
• Workhorse Group Inc. WKHS rose 6.3 percent to $2.12. B. Riley FBR initiated coverage on Workhorse with a Buy rating.
• Teligent, Inc. TLGT gained 6.2 percent to $3.93 after the company reported the FDA approval of Fluocinonide gel, 0.05%.

Check out these big penny stock gainers and losers

Losers

• Anika Therapeutics Inc ANIK shares dipped 35 percent to $30.00 after reporting top-line results from CINGAL 16-02 clinical trial in knee osteoarthritis study did not achieve statistical significance at primary endpoint.
• Astrotech Corporation ASTC dipped 23.1 percent to $4.89. Astrotech shares surged 217.44 percent Tuesday after the company’s subsidiary, 1st Detect, announced its TRACER 1000 Explosives Trace Detector was accepted into the European Evaluation Process for airport checkpoint screening.
• ReShape Lifesciences Inc. RSLS declined 19.8 percent to $2.60 after reporting a $1.5 million registered direct offering priced at-the-market.
• Gevo, Inc. GEVO shares dropped 18.2 percent to $15.96 after surging 53.54 percent on Tuesday.
• Solid Biosciences Inc. SLDB fell 16.2 percent to $36.04.
• Apollo Medical Holdings, Inc. AMEH declined 15.8 percent to $20.50.
• Catabasis Pharmaceuticals, Inc. CATB fell 15.4 percent to $0.8626 after the company reported pricing of its $42 million underwritten public offering.
• Kazia Therapeutics Limited KZIA dropped 13.5 percent to $3.7390.
• HomeTown Bankshares Corporation HMTA shares fell 11 percent to $13.35.
• Galectin Therapeutics, Inc. GALT slipped 9.2 percent to $8.13.
• Alarm.com Holdings, Inc. ALRM fell 7.9 percent to $41.73.
• Starbucks Corporation SBUX shares fell 7.5 percent to $53.16 after announcing weak third-quarter guidance and the closing of 150 stores.
• Oracle Corporation ORCL shares fell 6.2 percent to $43.410. Oracle reported better-than-expected earnings for its fourth quarter, but issued weak guidance for the first quarter.
• La-Z-Boy Incorporated LZB shares fell 4 percent to $31.95. La-Z-Boy reported upbeat earnings for its fourth quarter, while sales missed estimates.